With the World Health Organisation ranking diseases driven by chronic inflammation as the greatest threat to human health, our serendipitous finding that sEH controls the expansion of cells that are purported to be pathogenic in many chronic inflammatory diseases, suggested that inhibition of sEH may represent a tractable approach to treating chronic inflammation. This evidence concerns the gene EPHX2 and inflammation.